Findings represent first evidence of ALK activity in inflammatory breast cancer. Data emphasize importance of proteins and enzymes to define molecular biology. Identification of ALK pathway activation could allow for more targeted treatment. SAN FRANCISCO — Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may [...]
Read the complete post at http://aacrnews.wordpress.com/2011/11/13/signaling-pathway-linked-to-inflammatory-breast-cancer-may-drive-disease-metastasis/
Posted
Nov 13 2011, 11:00 AM
by
AACR News
Filed under: Press Releases, Research, Treatment, Breast Cancer, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, National Cancer Institute, NCI, Molecular Targets, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Cancer Therapeutics, EORTC, metastasis, European Organisation for Research and Treatment of Cancer, Dr. Fredika M. Robertson, inflammatory breast cancer, anaplastic lymphoma kinase, ALK, Dr. Massimo Cristofanilli